UK Companies House feature
HEALTHCARE CENTRAL LONDON LTD
Cash
£1M
-11.1% vs 2024
Net assets
£362K
-2.8% vs 2024
Employees
161
+29.8% vs 2024
Profit before tax
£4K
-98.2% vs 2024
Profile
- Company number
- 12573258
- Status
- Active
- Incorporation
- 2020-04-27
- Last accounts made up
- 2025-03-31
- Account category
- FULL
- Primary SIC
- 86210
- Hubs
- UK Healthcare
Net assets
6-year trend · vs UK Healthcare median
Accounts
6-year trend · latest 2025-03-31
| Metric | Trend | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2023-04-01 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £16,999,616 | £19,456,974 | |
| Operating profit | — | — | — | — | £213,748 | £11,166 | |
| Profit before tax | — | — | — | — | £213,748 | £3,917 | |
| Net profit | — | — | — | — | £153,077 | -£10,251 | |
| Cash | £4,390 | £4,390 | £4,390 | £4,390 | £1,530,292 | £1,361,121 | |
| Total assets less current liabilities | — | — | £219,500 | — | £372,577 | £367,227 | |
| Net assets | £219,500 | £219,500 | £219,500 | — | £372,577 | £362,326 | |
| Equity | £219,500 | £219,500 | £219,500 | — | £372,577 | £362,326 | |
| Average employees | 0 | 0 | 10 | — | 124 | 161 | |
| Wages | — | — | — | — | £4,985,447 | £6,033,923 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”
Significant events
- “During the year, HCL entered into two joint ventures with Octopus Health Limited and ZoomDoc Pro Ltd to develop technology solutions that improve patient care.”
- “Following the year end, the NWL ICB has merged with North Central London ICB (NCL).”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
12 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FULLMAN, Steven Ronald | Secretary | 2022-02-22 | — | — |
| ABU-MOUSTAFA, Sedra-Mariam | Director | 2025-04-28 | Jul 1987 | British |
| AGARWAL, Sree Kumar | Director | 2025-04-28 | Dec 1975 | British |
| BROWNE, Siobhan Deborah | Director | 2022-02-22 | Jun 1976 | British |
| CHOPRA, Rishi, Dr | Director | 2020-05-27 | Feb 1978 | British |
| KAUFMAN, Saul Daniel, Dr | Director | 2020-05-27 | Aug 1980 | British |
| KUMAR, Salene, Dr | Director | 2025-04-28 | May 1979 | British |
| MCNEILL BLACK, Kirsten | Director | 2022-02-22 | Jul 1969 | British |
| O'REILLY, Paul, Dr | Director | 2022-05-09 | Mar 1962 | British |
| ORROM SWAN, Clare Lianne, Dr | Director | 2025-12-05 | Sep 1987 | British |
| SAFA, Afsana Mumtaz, Dr | Director | 2020-09-14 | Jun 1980 | British |
| SCOTT, Nicholas David | Director | 2026-01-13 | Apr 1968 | Australian |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ABERCROMBIE, Matthew Peter | Director | 2024-04-23 | 2025-03-31 |
| BRAZIL, Joseph Paul | Director | 2020-04-27 | 2021-09-27 |
| DAVIS, Jonathan Miles | Director | 2020-08-25 | 2024-08-31 |
| JOHNSON, Matthew Anselm, Dr | Director | 2020-04-27 | 2020-09-13 |
| KONG, Etheldreda Kee Ching, Dr | Director | 2020-09-02 | 2021-08-31 |
| MANIERA, Djanan Meryem, Dr | Director | 2020-05-27 | 2025-05-29 |
| NEOGI, Sheila, Dr | Director | 2020-09-11 | 2025-04-01 |
| NIJJAR, Jasvinder | Director | 2020-04-27 | 2020-12-17 |
| SANDU, Ruth Codruta | Director | 2020-08-25 | 2025-04-01 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 62 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-14 | SH02 | capital | capital alter shares subdivision |
| 2026-03-13 | SH08 | capital | capital name of class of shares |
| 2026-02-24 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2026-01-20 | AP01 | officers | appoint person director company with name date |
| 2025-12-24 | AA | accounts | accounts with accounts type full |
| 2025-12-20 | SH02 | capital | capital alter shares subdivision |
| 2025-12-20 | SH08 | capital | capital name of class of shares |
| 2025-12-19 | AP01 | officers | appoint person director company with name date |
| 2025-09-03 | SH02 | capital | capital alter shares subdivision |
| 2025-09-03 | SH02 | capital | capital alter shares subdivision |
| 2025-09-03 | SH08 | capital | capital name of class of shares |
| 2025-09-03 | SH08 | capital | capital name of class of shares |
| 2025-09-02 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-07-03 | CH01 | officers | change person director company with change date |
| 2025-05-30 | TM01 | officers | termination director company with name termination date |
| 2025-05-08 | AP01 | officers | appoint person director company with name date |
| 2025-05-07 | AP01 | officers | appoint person director company with name date |
| 2025-05-07 | AP01 | officers | appoint person director company with name date |
| 2025-04-30 | TM01 | officers | termination director company with name termination date |
| 2025-04-30 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ (private-firm) · reference 2025-03-31
0.29
DISTRESS
Altman Z″
- Working capital / Total assets 0.029 × 6.56 = +0.19
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.002 × 6.72 = +0.02
- Book equity / Total liabilities 0.081 × 1.05 = +0.09
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory